Brandon Arolfo
arolfo.bsky.social
Brandon Arolfo
@arolfo.bsky.social
Marketer | Executive Producer
Emmy Winner | Grammy Loser
US + West Africa + Central America
Reposted by Brandon Arolfo
🚨 Exciting News! 🚨

AHA and the HCM Society are collaborating at AHA Scientific Sessions 2025!

Join us in New Orleans, Nov. 7, for groundbreaking HCM research at HCMS Scientific Session and AHA’s Scientific Sessions. Stay tuned for updates!

#AHA25

professional.heart.org/en/meetings/...
HCMS Scientific Sessions
The Hypertrophic Cardiomyopathy Medical Society (HSCM) will hold its annual scientific sessions meeting in conjunction with #AHA25 in New Orleans, HCMS Scientific Sessions is November 7, 2025. Find ou...
professional.heart.org
March 3, 2025 at 11:45 AM
Reposted by Brandon Arolfo
Can AI advance lifesaving cardiovascular and cerebrovascular care?

$12M is available to fund 3 investigators/teams proposing novel uses of artificial intelligence in health and health care delivery. Pre-proposals due Feb. 27.
February 20, 2025 at 6:00 AM
Reposted by Brandon Arolfo
🧠🎶👑⚜ Laissez les bons temps rouler ⚜️🎺🎷🧠

See you i#ISC26Orleans for #ISC26

📅 February 4-6
February 7, 2025 at 11:00 PM
Reposted by Brandon Arolfo
There's nothing like being in the room where it happens at #ISC25
February 6, 2025 at 9:12 PM
Reposted by Brandon Arolfo
C3FIT results presented at #ISC25
February 6, 2025 at 9:58 PM
Reposted by Brandon Arolfo
TRANSPORT2 Trial RESULTS: There were no significant differences in outcomes among the three intervention groups in patients post-stroke.

Watch for Erica Jones' perspective #ISC25
February 6, 2025 at 10:15 PM
Reposted by Brandon Arolfo
The Council on Stroke has awarded travel grants and Bernard J. Tyson Career Development Awards to 5 #ISC25 presenters from underrepresented racial and ethnic groups. Way to go!
February 6, 2025 at 11:00 PM
Reposted by Brandon Arolfo
CSC+ISPU compared to CSC improved post-stroke risk factors, with the greatest effects observed in diet, BP, & LDL-C.

However, did not result in better functional outcomes or health related QoL.

#ISC25
February 7, 2025 at 12:05 AM
Reposted by Brandon Arolfo
Erica Jones' take on TRANSPORT2 presented at #ISC25.

There were no significant differences in outcomes among the three intervention groups in patients post-stroke.
February 6, 2025 at 10:00 PM
Reposted by Brandon Arolfo
The C3FIT trial was a protocol-driven multicenter cluster-randomized trial.

Here is Chaturvedi Neuro’s perspective on the results a#ISC2525
February 6, 2025 at 10:10 PM
Reposted by Brandon Arolfo
No benefit from endovascular therapy treated patients versus medically managed patients. #ISC25

@jimsieglermd.bsky.social
February 5, 2025 at 11:29 PM
Reposted by Brandon Arolfo
Our research Mohammad Doheim presenting on the results of the POSITIVE trial at #ISC25
@news.upmc.com
February 5, 2025 at 4:43 PM
Reposted by Brandon Arolfo
What we’re talking about a#ISC2525, the world’s premier meeting on brain health and stroke science 🧠.
February 5, 2025 at 4:15 PM
Reposted by Brandon Arolfo
We're at #ISC25! Shannon Agner, MD, PhD, presented a talk titled, "A Neuroimmunology Framework to Diagnosing Inflammatory Vasculopathies."

Come find us and say hi!
February 5, 2025 at 5:48 PM
Reposted by Brandon Arolfo
Excited to be at #ISC25!

About to find out the results of the thrombectomy for medium vessel occlusions at the main event.
February 5, 2025 at 7:07 PM
Reposted by Brandon Arolfo
Today's the day! We're thrilled to be here with you in Los Angeles for #ISC25.

February 5, 2025 at 8:48 PM
Reposted by Brandon Arolfo
A total of $12 million in grant funding is available to fund 3 investigators/investigative teams proposing novel uses of Artificial Intelligence to revolutionize cardiovascular and cerebrovascular/brain health and health care delivery.

Learn more: professional.heart.org/en/research-...
Novel Artificial Intelligence Approaches to Advance Cardiovascular and Cerebrovascular/Brain Health
Research funding opportunity focused on novel AI approaches to advance cardiovascular and cerebrovascular/brain health
professional.heart.org
January 28, 2025 at 11:58 PM
Reposted by Brandon Arolfo
Watch sessions live, ask questions and earn CE credit from anywhere with the #ISC25 virtual experience. Join the premier meeting on cerebrovascular science Feb. 5-7.
January 23, 2025 at 6:00 PM
Reposted by Brandon Arolfo
Register now for the #ISC25 virtual experience. Hear all the latest results from the most impactful trials live, plus get on-demand access to all sessions and e-posters.
January 27, 2025 at 12:00 PM
Reposted by Brandon Arolfo
Thank you @ahascience.bsky.social #AHA24 Scientific Programming cttee @dramitkhera.bsky.social Dr JoChikweMD @daichishimbo.bsky.social & fellow #Science #Communicators!
#Gratitude & honoured to be part of this amazing meeting & team🙏

Safe travels #CardioSky👋
November 18, 2024 at 10:24 PM
Reposted by Brandon Arolfo
I was thrilled to meet my former trainees at #AHA24 in Chicago, IL, in the last few days!! @barefieldlab.bsky.social
November 17, 2024 at 4:49 PM
Reposted by Brandon Arolfo
VANISH2 looked at catheter ablation vs- drug therapy – sotalol or amiodarone (drug eligible) to treat ventricular tachycardia in persons with ischemic cardiomyopathy in persons with prior myocardial infarction. Watch this for perspective on the data #AHA24
November 17, 2024 at 2:07 PM
Reposted by Brandon Arolfo
Thank you so much for your kind feedback 😊 🙏@rantocran.bsky.social & for posting🙏
Hope we can connect at @ahascience.bsky.social #AHA24& welcome to #CardioSky🙌
November 16, 2024 at 11:40 PM
Reposted by Brandon Arolfo
At #AHA24, Dr. Nanette Wenger reminds us we’re all ‘standing on the shoulders of giants’ in healthcare. As we celebrate 100 years of Scientific Sessions, we honor the pioneers who paved the way and look ahead to a new century of innovation.
November 17, 2024 at 6:11 PM
Reposted by Brandon Arolfo
Tirzepatide is another option for managing obesity and CVD and improving quality of life in patients with HFpEF & obesity.

Watch this video for perspective on the data presented at #AHA24. #cardiology
November 16, 2024 at 8:01 PM